AVENUE THERAPEUTICS, INC. - Common Stock (ATXI) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2024 to Q1 2025

Type / Class
Equity / Common Stock
Symbol
ATXI on OTC
Shares outstanding
3,190,732
Price per share
$0.66
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of AVENUE THERAPEUTICS, INC. - Common Stock (ATXI) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Fortress Biotech, Inc. 13% +31% $290,370 +$73,398 439,955 +34% Fortress Biotech, Inc. 02 Jan 2026
Ikarian Capital, LLC 4.1% -39% $86,341 -$6,059 130,820 -6.6% Ikarian Capital, LLC 31 Dec 2025
ARMISTICE CAPITAL, LLC 5% $25,100 100,400 Armistice Capital, LLC 31 Dec 2024

Institutional Holders of AVENUE THERAPEUTICS, INC. - Common Stock (ATXI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q1 0 $0 -$385,256 $0.66 0
2024 Q4 192,628 $385,256 -$102,432 $2.00 7
2024 Q3 197,515 $491,813 +$202,123 $2.49 8
2024 Q2 116,349 $407,223 +$407,223 $3.50 8